|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C07H 21/04 | |||
| A61K 48/00 | |||
| C12N 15/113 |
| (11) | Patento numeris | 2640853 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11840796.4 |
| Europos patento paraiškos padavimo data | 2011-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/061245 |
| Data | 2011-11-17 |
| (87) | Numeris | WO 2012/068405 |
| Data | 2012-05-24 |
| (30) | Numeris | Data | Šalis |
| 414848 P | 2010-11-17 | US |
| (72) |
BENNETT, C., Frank, US
FREIER, Susan, M., US
MALLAJOSYULA, Jyothi, US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF ALPHA SYNUCLEIN EXPRESSION |
| MODULATION OF ALPHA SYNUCLEIN EXPRESSION |